Do the peak and mean force methods of assessing vertical jump force asymmetry agree?

Sports Biomechanics
Jason P LakeTimothy J Suchomel

Abstract

The aim of this study was to assess agreement between peak and mean force methods of quantifying force asymmetry during the countermovement jump (CMJ). Forty-five men performed four CMJ with each foot on one of two force plates recording at 1,000 Hz. Peak and mean were obtained from both sides during the braking and propulsion phases. The dominant side was obtained for the braking and propulsion phase as the side with the largest peak or mean force and agreement was assessed using percentage agreement and the kappa coefficient. Braking phase peak and mean force methods demonstrated a percentage agreement of 84% and a kappa value of 0.67 (95% confidence limits: 0.45-0.90), indicating substantial agreement. Propulsion phase peak and mean force methods demonstrated a percentage agreement of 87% and a kappa value of 0.72 (95% confidence limits: 0.51-0.93), indicating substantial agreement. While agreement was substantial, side-to-side differences were not reflected equally when peak and mean force methods of assessing CMJ asymmetry were used. These methods should not be used interchangeably, but rather a combined approach should be used where practitioners consider both peak and mean force to obtain the fullest picture of athlete a...Continue Reading

References

Jan 1, 1983·European Journal of Applied Physiology and Occupational Physiology·C BoscoP V Komi
Mar 3, 2005·Medicine and Science in Sports and Exercise·Ivy O W Man, Matthew C Morrissey
Aug 30, 2006·Journal of Strength and Conditioning Research·Brooke R LawsonRaoul F Reiser
Dec 30, 2006·Journal of Strength and Conditioning Research·Robert U NewtonWilliam J Kraemer
Jun 21, 2007·Research in Sports Medicine·Jay R HoffmanJie Kang
Nov 8, 2007·Medicine and Science in Sports and Exercise·Franco M ImpellizzeriSamuele M Marcora
Dec 14, 2007·Journal of Strength and Conditioning Research·Sean P Flanagan, George J Salem
Apr 24, 2009·Journal of Strength and Conditioning Research·Carson PattersonHans-Peter Platzer
Jan 12, 2012·Journal of Strength and Conditioning Research·Dimitri CeroniNathalie J Farpour-Lambert
Jul 17, 2012·Journal of Strength and Conditioning Research·Hans-Joachim MenzelFabianna Resende de Jesus-Moraleida
Jan 5, 2013·Journal of Strength and Conditioning Research·Nat BenjanuvatraBrian A Blanksby
Nov 28, 2013·Journal of Strength and Conditioning Research·Nick J OwenMark A Bennett
Jan 10, 2014·Journal of Strength and Conditioning Research·David R BellBryan C Heiderscheit
Mar 4, 2014·Journal of Strength and Conditioning Research·Jason P LakePaul Comfort
Sep 13, 2014·Scandinavian Journal of Medicine & Science in Sports·M J JordanW Herzog
Jan 3, 2015·Journal of Sports Sciences·Carlos Balsalobre-FernándezRichard Anthony Lockey
May 7, 2015·Journal of Strength and Conditioning Research·Christopher A BaileyMichael H Stone
Sep 12, 2015·International Journal of Sports Physiology and Performance·Timothy J SuchomelMichael H Stone
Jul 2, 2016·The Veterinary Record
Sep 27, 2016·Journal of Strength and Conditioning Research·Harry G BanyardG Gregory Haff
Mar 12, 2017·Journal of Sports Sciences·Peter D MundyJason P Lake
Jun 13, 2017·International Journal of Sports Physiology and Performance·John J McMahonPaul Comfort

❮ Previous
Next ❯

Software Mentioned

VICON Nexus

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.